PROSPECT guidelines for oncological breast surgery: the role of non-opioid analgesics, a reply
- PMID: 33015825
- DOI: 10.1111/anae.15266
PROSPECT guidelines for oncological breast surgery: the role of non-opioid analgesics, a reply
Comment on
-
PROSPECT guidelines for oncological breast surgery: the role of non-opioid analgesics.Anaesthesia. 2021 Jan;76(1):139-140. doi: 10.1111/anae.15259. Epub 2020 Sep 13. Anaesthesia. 2021. PMID: 32920847 No abstract available.
References
-
- Stamer UM, Stüber F. PROSPECT guidelines for oncological breast surgery: the role of non-opioid analgesics. Anaesthesia 2020; 76: 138-9.
-
- Jacobs A, Lemoine A, Joshi GP, Van de Velde M, Bonnet F; PROSPECT working group collaborators. PROSPECT guideline for oncological breast surgery: a systematic review and procedure-specific postoperative pain management recommendations. Anaesthesia 2020; 75: 664-73.
-
- Joshi GP, Van de Velde M, Kehlet H, et al. Development of evidence-based recommendations for procedure-specific pain management: PROSPECT methodology. Anaesthesia 2019; 74: 1298-304.
-
- Kampe S, Warm M, Landwehr S, et al. Clinical equivalence of IV paracetamol compared to IV dipyrone for postoperative analgesia after surgery for breast cancer. Current Medical Research and Opinion 2006; 22: 1949-54.
-
- Ohnesorge H, Bein B, Hanss R, et al. Paracetamol versus metamizol in the treatment of postoperative pain after breast surgery: a randomized, controlled trial. European Journal of Anaesthesiology 2009; 26: 648-53.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
